SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-024484
Filing Date
2022-04-14
Accepted
2022-04-14 19:54:14
Documents
1
Period of Report
2022-04-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3890
  Complete submission text file 0001209191-22-024484.txt   5269
Mailing Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-466-7125
ALX ONCOLOGY HOLDINGS INC (Issuer) CIK: 0001810182 (see all company filings)

IRS No.: 850642577 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O ALX ONCOLOGY HOLDINGS INC 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Canamasas Itziar (Reporting) CIK: 0001921346 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39386 | Film No.: 22828720